Literature DB >> 12745796

Women--a neglected risk group for atherosclerosis and vascular disease.

Leif R Erhardt1.   

Abstract

Women are a neglected group for cardiovascular disease. Whereas young women tend to have lower incidences of coronary artery disease, stroke and myocardial infarctions than men, the situation changes drastically at menopause, after which women are at greater risk than men. Despite this, women at all ages receive less treatment, less attention and not enough information about health risks. Most risk factors, e.g. hypertension, elevated blood lipid levels, diabetes and changes in oestrogen levels, differ between women and men. As a consequence of this, secondary prevention from coronary artery disease is likely to have different effects in women to those in men. Different kinds of antihypertensive therapy, hormone-replacement therapy and lipid-lowering treatment may be more or less suitable in women than in men. The recent development of angiotensin-receptor blockers may have beneficial effects which make them particularly effective in women.

Entities:  

Mesh:

Year:  2003        PMID: 12745796     DOI: 10.1080/14017430310006965

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  2 in total

1.  Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.

Authors:  Samy I McFarlane; Jonathan Castro; Jasjeet Kaur; John J Shin; Douglas Kelling; Amal Farag; Nicole Simon; Fadi El-Atat; Alan Sacerdote; Emad Basta; John Flack; George Bakris; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

2.  Testosterone and dihydrotestosterone reduce platelet activation and reactivity in older men and women.

Authors:  Kamil Karolczak; Lucyna Konieczna; Tomasz Kostka; Piotr J Witas; Bartlomiej Soltysik; Tomasz Baczek; Cezary Watala
Journal:  Aging (Albany NY)       Date:  2018-05-02       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.